FDA is hoping to provide Manufacturers of minimally invasive glaucoma surgical (MIGS) devices with a more clear-cut path to market with a newly finalized FDA guidance document .
FDA considers the document a “leap frog guidance,” meaning it provides initial recommendations on an emerging medical device technology and...